<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Defining an adequate resection margin of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> is essential for optimizing surgical technique </plain></SENT>
<SENT sid="1" pm="."><plain>We have attempted to evaluate the resection margin through a combination of histopathologic and genetic analyses </plain></SENT>
<SENT sid="2" pm="."><plain>EXPERIMENTAL DESIGN: We evaluated 88 samples of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> margins from 12 patients with metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> who each underwent partial hepatectomy of one to six <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Punch biopsies of surrounding liver tissue were obtained at 4, 8, 12, and 16 mm from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> border </plain></SENT>
<SENT sid="4" pm="."><plain>DNA from these biopsies was analyzed by a sensitive PCR-based technique, called BEAMing, for mutations of KRAS, PIK3CA, APC, or TP53 identified in the corresponding <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mutations were identified in each patient's resected <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and used to analyze the 88 samples circumscribing the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-<z:mpath ids='MPATH_458'>normal</z:mpath> border </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e>-specific mutant DNA was detectable in surrounding liver tissue in 5 of these 88 samples, <z:hpo ids='HP_0000001'>all</z:hpo> within 4 mm of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> border </plain></SENT>
<SENT sid="7" pm="."><plain>Biopsies that were 8, 12, and 16 mm from the macroscopic visible margin were devoid of detectable mutant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA and of microscopically visible <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> with a significant radiologic response to chemotherapy were not associated with any increase in mutant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA in beyond 4 mm of the main <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Mutant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific DNA can be detected beyond the visible <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> margin, but never beyond 4 mm, even in patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were larger prior to chemotherapy </plain></SENT>
<SENT sid="10" pm="."><plain>These data provide a rational basis for determining the extent of surgical excision required in patients undergoing resection of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>